$PAVM

PAVmed (NASDAQ: PAVM) Scott Dols reports 5.4% stake, 346,155 shares

Scott V. Dols has reported a beneficial ownership of 346,155 shares, representing a 5.4% stake in PAVmed Inc. (NASDAQ: PAVM). This disclosure was made via a Schedule 13G SEC filing, based on 6,383,089 shares outstanding as of March 27, 2026. Dols holds sole voting and dispositive power over these shares, which include 230,770 shares held in a trust where he serves as trustee.

Original reporting
Published Apr 9, 2026, 5:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 9, 2026, 5:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$PAVM
Bullish
medium confidence
Mentioned
$PAVM
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$PAVMBullishMed
01

Why it matters

The increased insider stake could be perceived as a vote of confidence, potentially boosting investor confidence and stock price.

02

Market read

The insider stake disclosure is relevant for investors monitoring insider activity and company confidence signals.

03

What to watch

Market conditions, overall sector performance, and company fundamentals should be considered before acting on insider activity.

Timing: Immediate, as the disclosure is recent and may influence trading decisions.

Background

Scott Dols' disclosure of a 5.4% stake in PAVmed Inc. was made via a Schedule 13G SEC filing, indicating passive ownership and not necessarily strategic control.

Company-level read

Ticker impact

$PAVMBullishMedium confidence
Context

The reported 5.4% ownership stake by Scott Dols in PAVmed Inc. indicates a significant insider position, which could influence market perception.

Expected impact

Moderate upward price movement expected over the short to medium term.

Evidence & confidence

Insider ownership changes can influence investor sentiment; however, as this is a passive disclosure without additional strategic actions, the impact may be limited.

Market effects

Potential positive sentiment for biotech and healthcare sectors, especially companies with active insider trading or ownership disclosures.

Limited, as the news pertains specifically to a U.S.-listed company and insider activity.

Minimal, unless PAVmed Inc. is part of a broader industry trend or strategic move.

Counterpoint

Insider ownership increases do not always translate to positive market performance; some insiders may acquire shares for reasons unrelated to company prospects.

Key entities

  • Scott V. Dols

    Investor who reported a 5.4% stake in PAVmed Inc.

  • PAVmed Inc.

    NASDAQ-listed medical device and digital health company.

Related articles

$PAVMMed

PAVmed Inc. (PAVM): Results of Operations and Financial Condition

PAVmed Inc. (PAVM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results Veris Health accelerated its commercial engagement with OSU-The James Veris Health implantable physiological monitor achieved development milestones towards

$TSNMed

Tyson to Close More Beef Plants as Cattle Shortage Drags On

Tyson Foods said it will shut an Illinois beef plant and a Utah case-ready facility and pursue the sale of a Washington plant, citing a prolonged US cattle shortage. Tyson plans to run beef operations around three plants in Nebraska, Kansas and Texas, with Amarillo shifting back to two shifts when cattle are available. Barclays estimates Tyson capacity fell about 10,000 head/day since 2025.

$BAMed

«البنتاغون»: إبرام اتفاقيتين لتسريع إنتاج الصواريخ الاعتراضية

The US Pentagon said it signed two agreements with Boeing and RTX to speed production of key components for Standard Missile-3 Block IB and increase components for Standard Missile-3 Block IIA. The missiles support ship-based air and ballistic missile defense under the Aegis system. The article also cites US defense budget requests of $1.5 trillion and production capacity targets for SM-3.

$DGXXMed

Digi Power X reports first AI compute revenue, reaffirms $1.1 billion Alabama contract

Digi Power X (NASDAQ:DGXX) reported Q2 revenue of about $6.6M and its first AI compute revenue, about $1.1M from GPU bare-metal rental over five weeks. It invested about $30M in GPU infrastructure (0.6 MW). Adjusted EBITDA rose to about $3.3M; net loss was about $14.4M. It reaffirmed a $1.1B 10-year Alabama contract, with Phase 1 15 MW due Dec 2026 and Phase 2 25 MW by Mar 2027.

$NXEMed

A uranium mine just broke ground in Saskatchewan. It could one day be among world’s largest

NexGen Energy Ltd. says construction has begun on its Rook I underground uranium project in Saskatchewan’s Athabasca Basin. The company expects four years of construction and production starting in late 2030, targeting up to 30 million pounds of uranium annually. NexGen estimates $32.5 billion in economic impact for Saskatchewan. The project will be licensed by Canada’s nuclear regulator.